SummaryCD40 plays an important role in B cell activation, proliferation, and Ig class switching. The signal transduction pathway mediated by CD40 was studied using monoclonal antibody (mAb) 626.1 to CD40. Burkitt's lymphoma and Epstein-Barr virus-transformed B cell lines and tonsilar B lymphocytes were treated with the anti-CD40 mAb for various lengths of time. The early events triggered by CD40 were examined by monitoring the changes in tyrosine phosphorylation of cellular proteins with anti-phosphotyrosine mAb. Dephosphorylation of specific proteins ranging between 50-110 kD and the appearance of a 28-kD tyrosine phosphorylated protein were seen within 30 s in human B cell lines. The dephosphorylation was reversed and the 28-kD protein was dephosphorylated in cells stimulated for 1 min. In resting B cells, the appearance of the 28-kD phosphoprotein was observed in 30 s after the addition of the anti-CD40 mAb. The tyrosine phosphorylation of this protein persisted. The patterns of protein tyrosine phosphorylation differed from those induced by an anti-immunoglobulin M mAb. The changes in the state of tyrosine phosphorylation induced by the anti-CD40 mAb were obviated by mAb to CD45, a protein tyrosine phosphatase (PTP) or by the addition of sodium orthovanadate, a broad PTP inhibitor. They were also blocked by protein tyrosine kinase (FFK) inhibitors, herbimycin A and genistein, and PKC and protein serine/threonine kinase inhibitors, H7 and HA1004. In addition, the alteration in the tyrosine phosphorylation ofPTKs Lyn, Fyn, and Syk was directly demonstrated. Engagement of CD40 for 30 s induced a transient decrease in tyrosine phosphorylation of these PTKs. These results indicate that the early events in CD40 signaling involve the complex interaction between PTP and protein kinases. C D40 is a 47-50-kD glycoprotein expressed on B cells and some normal and neoplastic epithelial cells including follicular dendritic cells and thymic epithelium (1-8). The cDNA sequences of both human and murine CD40 show that these glycoproteins are type I transmembrane proteins and contain cysteine-rich extracellular domains followed by serine/threonine-rich regions preceding the transmembrane domain (9, 10). They have significant homology to the members of the nerve growth factor receptor family (9-11).CD40 plays an important role in B cell activation, differentiation, and survival. Heterologous Abs and mAbs to CD40 induce B cell proliferation (1, 2, 4, 12, 13) and the engagement of CD40 by mAb provides a stimulatory signal synergistic with those delivered by IL-4 or Ab to either surface IgM (slgM) 1 or CD20 (2,14,15). An anti-CD40 mAb in the presence of IL-4 promotes long-term B cell growth (16). CD40 also plays a role in the induction of homotypic adhesion (17,18). A mAb to CD40 induces bcl-2 expression and Parts of these results have been presented in abstract form at the Annual Meeting AAP/ASCI/AFCR in